Related Experiment Video
Updated: Aug 3, 2026
Single-cell Profiling of Developing and Mature Retinal Neurons
Published on: April 19, 2012
Exploring (novel) gene expression during retinoid-induced maturation and cell death of acute promyelocytic leukemia
G R Benoit1, J H Tong, Z Balajthy
1INSERM U-496, Institut Universitaire d'Hématologie, H pital Saint-Louis, Paris, France.
Abstract:
During recent years, reports have shown that biological responses of acute promyelocytic leukemia (APL) cells to retinoids are more complex than initially envisioned. PML-RARalpha chimeric protein disturbs various biological processes such as cell proliferation, differentiation, and apoptosis. The distinct biological programs that regulate these processes stem from specific transcriptional activation of distinct (but overlapping) sets of genes. These programs are sometimes mutually exclusive and depend on whether the signals are delivered by RAR or RXR agonists. Furthermore, evidence that retinoid nuclear signaling by retinoid, on its own, is not enough to trigger these cellular responses is rapidly accumulating. Indeed, work with NB4 cells show that the fate of APL cells treated by retinoid depends on complex signaling cross-talk. Elucidation of the sequence of events and cascades of transcriptional regulation necessary for APL cell maturation will be an additional tool with which to further improve therapy by retinoids. In this task, the classical techniques used to analyze gene expression have proved time consuming, and their yield has been limited. Global analyses of the APL cell transcriptome are needed. We review the technical approaches currently available (differential display, complementary DNA microarrays), to identify novel genes involved in the determination of cell fate.
Insights
Retinoids trigger complex responses in acute promyelocytic leukemia (APL) cells, involving PML-RARalpha protein and gene regulation. Understanding these pathways is crucial for improving retinoid therapy for APL.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Biological responses of acute promyelocytic leukemia (APL) cells to retinoids are complex.
- The PML-RARalpha chimeric protein disrupts cell proliferation, differentiation, and apoptosis.
- Retinoid signaling involves specific transcriptional activation of gene sets, influenced by RAR or RXR agonists.
Purpose of the Study:
- To explore the complex signaling cross-talk influencing APL cell fate upon retinoid treatment.
- To identify novel genes involved in APL cell maturation and determination of cell fate.
- To improve retinoid therapy for APL by elucidating transcriptional regulation cascades.
Main Methods:
- Review of technical approaches for global transcriptome analysis in APL cells.
- Discussion of differential display and complementary DNA (cDNA) microarrays.
- Analysis of gene expression patterns to understand cell fate determination.
Main Results:
- Retinoid signaling alone is insufficient to trigger cellular responses in APL.
- APL cell fate depends on complex signaling cross-talk, particularly in NB4 cells.
- Classical gene expression techniques are time-consuming and have limited yield.
Conclusions:
- Global transcriptome analysis is needed to identify novel genes in APL cell fate determination.
- Elucidating the sequence of events and transcriptional regulation cascades can improve retinoid therapy.
- Further research into APL cell signaling pathways is essential for therapeutic advancements.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:15Differentiation of Common Myeloid Progenitor Cells